title: Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes.
authors.affiliation: Department of Pediatrics, Case Western Reserve University, MetroHealth Medical Center, Cleveland, Ohio 44109, USA.
authors.forename: Monica
authors.initials: M
authors.lastname: Garcia
authors.forename: Maroun J
authors.initials: MJ
authors.lastname: Mhanna
authors.forename: Moon-Ja
authors.initials: MJ
authors.lastname: Chung-Park
authors.forename: Pamela H
authors.initials: PH
authors.lastname: Davis
authors.forename: Maya D
authors.initials: MD
authors.lastname: Srivastava
mesh_terms: D001649:Bile Duct Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D001653:Bile Ducts, Intrahepatic / Q000473:pathology*; D002220:Carbamazepine / Q000009:adverse effects*; D002675:Child, Preschool; D002779:Cholestasis / Q000150:complications; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D010195:Pancreatitis / Q000150:complications; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000188:drug therapy*; D016559:Tacrolimus / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D002220:Carbamazepine; D016559:Tacrolimus; D008775:Methylprednisolone